Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
about
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareGold-based drug encapsulation within a ferritin nanocage: X-ray structure and biological evaluation as a potential anticancer agent of the Auoxo3-loaded proteinIn Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.Auranofin, an anti-rheumatic gold compound, modulates apoptosis by elevating the intracellular calcium concentration ([ca2+]I) in mcf-7 breast cancer cells.A quantitative proteomics-based signature of platinum sensitivity in ovarian cancer cell lines.Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug research.Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Gallium phosphinoarylbisthiolato complexes counteract drug resistance of cancer cells.Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: a comparative proteomic study.In vitro antineoplastic effects of auranofin in canine lymphoma cells.Gold(iii) complexes inhibit growth of cisplatin-resistant ovarian cancer in association with upregulation of proapoptotic PMS2 geneA dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo
P2860
Q26851160-6EAE2599-A160-410F-B398-EA138EA0F1F5Q27712597-FE4EC283-D46D-41CD-A703-9DDF43F1056BQ31148784-73C5C06A-66CB-4689-A239-6D80DA020DC4Q34774888-D0C1E382-C8A9-429E-93D0-A3F391DA1C4AQ35031170-423B776B-A98F-49CD-A8AA-F51797A1FAC0Q36268494-EFC8CE58-5B6C-4A1D-BAA4-488BB89501C2Q38052406-63A07AED-8512-4CEB-ABB3-603BA3F7DB97Q39035304-E651DE08-6B80-40D7-B4A7-529EAF883414Q55408356-53744EA4-EBD6-4977-AC9C-F45895CABDBBQ55429885-54F2AB3F-F90B-4C37-9947-7F5E01780755Q58921526-B27DB780-3D97-4F21-99C2-31CB221F3102Q58921543-7E56B7BB-A705-4B4F-BC95-F531CF04A103
P2860
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
@en
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
@nl
type
label
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
@en
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
@nl
prefLabel
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
@en
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
@nl
P2093
P2860
P50
P356
P1433
P1476
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds.
@en
P2093
Enrico Mini
Francesca Guidi
Ida Landini
Maria Agostina Cinellu
Michele Puglia
Stefania Nobili
Tania Fiaschi
P2860
P304
P356
10.1039/C2MT00083K
P577
2012-02-10T00:00:00Z